The novel therapy of the medication represents a major advance in the management of the condition. Different to existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide882215.suomiblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57972368